Logo



 

  (format: symbol-exchange code e.g. IBM-N)

Exchange Codes:  T-Toronto N-New York A-American Q-Nasdaq I-Index
  • Stock Trends Report
  • Charting
  • Industry
  • Profile
  • Social
NYSE LABU
week ending
Friday Jul 20, 2018
   
Direxion Daily S&P Biotech Bull 3X Share
Trend Trend Counters Relative Strength  
(Strong) Bullish Trend. The closing price is above the lower limit of the 13-week MA envelope. This indicates that the short-term bullish trend of the stock's price remains relatively strong. Trading implication: generally considered positive in terms of both trade entry and holding.
Trend / Category
11/ 97
13 week Current wk Unusual Volume
130 -
n/a
  weeks in vs. S&P500  
Trading stats for the Week Stock Trends chart of Direxion Daily S&P Biotech Bull 3X Share $LABU - click for more ST charts
  Close Range
$US 109.55 104.24 - 112.48
1 week %change 13 week %change
-1.5% +36.3%
Average Price
13 week MA 40 week MA
96.95 88.04
52-week range
55.10 - 116.54
Share Volume Relative Volume
2,963,500 ~
Total traded value
$324,651,425
Historical ST Data | ST Charts
Direxion Daily S&P Biotech Bull 3X Share (LABU-N)
Trend Rel
Str
+
-
52wk
Hi | Lo
Stock Name
Symbol
Wk Close
Wk
%Chg
Wk
Range
Vol (00's)
Hi/Lo Vol
No Stock Data
Highlighted stocks traded at their 52 week high or low, OR gained/lost more than 10% during the trading week.
Business Description :
The investment seeks daily investment results, of 300% of the performance of the S&P Biotechnology Select Industry Index ("index"). The index is provided by S&P and includes domestic companies from the biotechnology industry. The fund normally creates long positions by investing at least 80% of its assets in the securities that comprise the index and/or financial instruments that provide leveraged and unleveraged exposure to the index. These financial instruments include: swap agreements; options on securities and indices; forward contracts; reverse repurchase agreements; ETFs; and other financial instruments. The fund is non-diversified.
Company Website :
N/A
  Privacy Policy  |   Terms of Use  |   Syndications  |   Contact Us